Mumbai, India

Sanjeev Kulkarni

USPTO Granted Patents = 4 

Average Co-Inventor Count = 7.2

ph-index = 4

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 2007-2012

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovator Profile: Sanjeev Kulkarni

Introduction: Sanjeev Kulkarni is a renowned inventor based in Mumbai, India. With a total of four patents to his name, he has made significant contributions to the field of pharmaceutical sciences, particularly in the area of cyclin-dependent kinase inhibition. His groundbreaking work paves the way for potential cancer treatments and showcases his innovative spirit.

Latest Patents: One of Sanjeev Kulkarni's most notable patents is titled "Inhibitors of Cyclin Dependent Kinases and Their Use." This invention pertains to novel compounds designed to inhibit cyclin-dependent kinases, particularly focusing on chromenone derivatives of a specific formula. The implications of this invention are far-reaching, as it relates to the treatment and prevention of diseases such as cancer by hindering cell proliferation. The patent also addresses the processes for creating these compounds and the formulation of medicaments that can be combined with suitable carrier substances.

Career Highlights: Throughout his career, Sanjeev Kulkarni has been associated with leading companies in the healthcare sector, such as Piramal Healthcare Limited and Piramal Life Sciences Ltd. His dedication to research and innovation has established him as an influential figure in pharmaceutical development.

Collaborations: Sanjeev has worked alongside esteemed colleagues, including Bansi Lal and Kalpana Sanjay Joshi. Their collaborative efforts have further advanced the research in the field and contributed to the successful development of innovative medicinal compounds.

Conclusion: In summary, Sanjeev Kulkarni's innovative contributions to the field of cyclin-dependent kinase inhibitors exemplify the impact of dedicated inventors in the healthcare domain. His work not only broadens the understanding of potential cancer treatments but also serves as a testament to the importance of collaboration in scientific advancements. As he continues to innovate, Sanjeev Kulkarni remains a pivotal figure in the realm of pharmaceutical inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…